What's Wrong With Clinical Trials

Clinical trials do not serve the patients' best interests. Clinical trials are designed to serve science, the scientific community, and pharmaceutical companies that can potentially profit from them. This is quite clearly not in the best interest of the patient, in that participation in clinical trials does not offer the patient the best chance of survival.

While oncologists often promote clinical trials as a great opportunity for patients to have access to potentially lifesaving cutting-edge drugs, a closer look at how the system really works reveals clinical trials are analogous to guinea pigs playing a game of Russian roulette, all the while non-toxic treatments that have been shown to extend average lifespan by large multipliers are completely ignored.

From a logical perspective, would you rather participate in a placebo-controlled clinical trial, with a 50% chance of receiving a placebo, and a 50% chance of receiving one single drug that is still unproven in both efficacy and safety, or benefit from the research done in hundreds of clinical trials from around the world, and begin using multiple non-toxic agents that have shown promising results?

To understand why clinical trials are more life-threatening than life-saving, please read the following quotes from Harvard-trained scientist and long term cancer survivor, Ben Williams' book "Surviving Terminal Cancer"

(add quotes from Surviving Terminal Cancer)

The tale of our friend Maggie McGee's, author of the book "How I beat Stage 4 Cancer" involvement with clinical trials serves as a cautionary note to all cancer patients. Together with 8 other patients, Maggie got into a clinical trial for chemotherapy to treat her stage four colon cancer, metastasized to the lung, liver and both breasts. The eight others were all dead in six months, but not from cancer. It was the chemotherapy that killed them all. 

Maggie was in touch with her own body enough to realize that the chemo was killing her too so she dropped out of the trial after three months, swore to never again take chemo, and began a journey of self-education and healing, which is documented in her book. 

 After nearly 11 years of obfuscation and denial surrounding the tragic death of Dan Markingson, the University of Minnesota has suspended enrollment in psychiatric drug trials. This comes in response to a blistering report issued by the Minnesota State Legislative Auditor that cites “serious ethical issues” and vindicates much of the reporting in the story below. Read more from Carl Elliott about the fallout from the report here.